C

Check-Cap Ltd
D

CHEK

0.87220
USD
0.05
(6.37%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-0
Market Cap
5,101,686
OverviewSignalsIdeasNews
Related Instruments
    A
    ADAP
    -0.05000
    (-3.79%)
    1.27000 USD
    A
    AEMD
    -0.00790
    (-2.33%)
    0.33120 USD
    A
    AGEN
    -0.05000
    (-0.83%)
    5.99000 USD
    A
    AKBA
    -0.10000
    (-7.25%)
    1.28000 USD
    B
    BCLI
    -0.01260
    (-3.67%)
    0.33030 USD
    B
    BLCM
    -0.01620
    (-4.09%)
    0.36000 USD
    E
    ETON
    -0.06000
    (-1.65%)
    3.58000 USD
    S
    SCYX
    -0.11000
    (-5.14%)
    2.03000 USD
    More
News

Title: Check/Cap Ltd

Sector: Healthcare
Industry: Diagnostics & Research
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.